Streetbeat News

Analyst Ratings

ELF

Stifel analyst Mark Astrachan has maintained a Hold rating on e.l.f. Beauty (NYSE:ELF) and increased the price target from $119 to $141. This adjustment reflects a more positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:24 pm

PCTY

JMP Securities analyst Patrick Walravens has reiterated a 'Market Outperform' rating on Paylocity Holding (NASDAQ:PCTY) and maintained a price target of $250. This endorsement reflects a positive outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:24 pm

NICE

JMP Securities analyst Patrick Walravens has reiterated a 'Market Outperform' rating on NICE Ltd. (NASDAQ:NICE) and maintained a price target of $343. This reaffirmation of the stock's potential could influence investor sentiment and potentially impact the stock's short-term performance.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:20 pm

MDB

JMP Securities analyst Patrick Walravens has reiterated a 'Market Outperform' rating on MongoDB (NASDAQ:MDB) and maintained a price target of $440. This reaffirmation of the stock's potential could influence investor sentiment and market activity related to MongoDB's shares.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:18 pm

DOCU

JMP Securities analyst Patrick Walravens has reiterated a 'Market Outperform' rating on DocuSign (NASDAQ:DOCU), maintaining a price target of $84.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:17 pm

CRM

JMP Securities analyst Patrick Walravens has reiterated a 'Market Outperform' rating on Salesforce (NYSE:CRM) and maintained a price target of $293.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:13 pm

FWRD

Stifel analyst J. Bruce Chan has maintained a Hold rating on Forward Air (NASDAQ:FWRD) but has reduced the price target from $80 to $55.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:09 pm

SGMT

JMP Securities analyst Jonathan Wolleben has maintained a Market Outperform rating on Sagimet Biosciences (NASDAQ:SGMT) and increased the price target from $31 to $47.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 8:06 pm

AAPL

AMZN

GOOG

META

MSFT

NVDA

TSLA

Jim Cramer has suggested removing Tesla Inc (TSLA) from the 'Magnificent Seven', a group of mega-cap tech stocks, renaming it the 'Super Six'. This comes as Tesla shares have dropped approximately 16% in 2024 and are in a downtrend since late 2021. Morgan Stanley analyst Adam Jonas cut Tesla's earnings, margins, and free cash flow estimates ahead of its quarterly results. Tesla's operating margins have also decreased significantly year-over-year. Investors are awaiting Tesla's earnings report, with expectations of 74 cents per share on $25.547 billion in revenue.

Portfolio Pulse from Adam Eckert

January 22, 2024 | 8:05 pm

TCBI

Texas Capital Bancshares (NASDAQ:TCBI) received mixed ratings from 10 analysts in the past three months, with an average 12-month price target of $68.3, a slight decline from the previous average. Ratings range from 'Overweight' to 'Neutral', with recent actions including both raised and lowered price targets. The company faces challenges with a negative revenue trend, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio. Analysts' ratings are based on in-depth financial analysis and market conditions.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 8:01 pm